The anti-tumor agent, p-DDAP potently suppresses proliferation through apoptosis in human neuroblastoma NB-39-nu cells
- 1 November 2010
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 297 (2) , 252-258
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
- Daiichi Sankyo Foundation of Life Science
This publication has 18 references indexed in Scilit:
- Long-Term Results for Children With High-Risk Neuroblastoma Treated on a Randomized Trial of Myeloablative Therapy Followed by 13-cis-Retinoic Acid: A Children's Oncology Group StudyJournal of Clinical Oncology, 2009
- Reduced risk of secondary leukemia with fewer cycles of dose‐intensive induction chemotherapy in patients with neuroblastomaPediatric Blood & Cancer, 2009
- Identification of ALK as a major familial neuroblastoma predisposition geneNature, 2008
- Retinoic acid induces caspase-8 transcription via phospho-CREB and increases apoptotic responses to death stimuli in neuroblastoma cellsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2008
- High-dose rapid and standard induction chemotherapy for patients aged over 1 year with stage 4 neuroblastoma: a randomised trialThe Lancet Oncology, 2008
- Bcl-2 is a key regulator for the retinoic acid-induced apoptotic cell death in neuroblastomaOncogene, 2006
- Retinoic acid receptors and tissue-transglutaminase mediate short-term effect of retinoic acid on migration and invasion of neuroblastoma SH-SY5Y cellsOncogene, 2005
- Treatment of High-Risk Neuroblastoma with Intensive Chemotherapy, Radiotherapy, Autologous Bone Marrow Transplantation, and 13-cis-Retinoic AcidNew England Journal of Medicine, 1999
- Phase IIa Study of Fenretinide in Superficial Bladder Cancer, Using DNA Flow Cytometry as an Intermediate End PointJNCI: Journal of the National Cancer Institute, 1994
- Phase II study of Fenretinide (N-[4-Hydroxyphenyl]retinamide) in advanced breast cancer and melanomaInvestigational New Drugs, 1990